GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Corp (OTCPK:ALID) » Definitions » ROCE %

ALID (Allied) ROCE % : 0.00% (As of May. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Allied ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Allied's annualized ROCE % for the quarter that ended in May. 2024 was 0.00%.


Allied ROCE % Historical Data

The historical data trend for Allied's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied ROCE % Chart

Allied Annual Data
Trend Mar18 Mar19 Aug20 Aug21 Aug22 Aug23
ROCE %
Get a 7-Day Free Trial - -324.79 -620.36 - -

Allied Quarterly Data
Jun19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Allied ROCE % Calculation

Allied's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=-9.812/( ( (5.79 - 6.907) + (2.064 - 8.85) )/ 2 )
=-9.812/( (-1.117+-6.786)/ 2 )
=-9.812/-3.9515
=248.31 %

Allied's ROCE % of for the quarter that ended in May. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: May. 2024 )  (Q: Feb. 2024 )(Q: May. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: May. 2024 )  (Q: Feb. 2024 )(Q: May. 2024 )
=-2.708/( ( (2.29 - 9.72) + (2.21 - 9.8) )/ 2 )
=-2.708/( ( -7.43 + -7.59 )/ 2 )
=-2.708/-7.51
=0 %

(1) Note: The EBIT data used here is four times the quarterly (May. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied  (OTCPK:ALID) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Allied ROCE % Related Terms

Thank you for viewing the detailed overview of Allied's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Business Description

Traded in Other Exchanges
N/A
Address
1405 St. Paul Street, Suite 201, Kelowna, BC, CAN, V1Y 9N2
Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions. The company uses an evidence-informed scientific approach to make this mission possible through cutting-edge pharmaceutical research and development, plant-based production, and the development of therapeutic products. The company operates in two segments which include Allied and Allied Colombia. Its geographical segments consist of Colombia and Canada. The company's revenue is comprised ofsales ofcannabis products.
Executives
James George Robinson director, 10 percent owner 10 EAST LEE STREET, SUITE 2705, BALTIMORE MD 21202
Anthony Zelen director, 10 percent owner 1406 MINE HILL LANE, KELOWNA A1 V1P 1S5
Calum Hughes director, 10 percent owner, officer: Chief Executive Officer 1847 CROSSGLEN COURT, KELOWNA A1 V1V 1S4
David Weinkauf director, 10 percent owner, officer: Chief Business Development Off 192 SIERRA MORENA LANDING, SW CALGARY A0 T3H 4K4
Paul James Bullock director, 10 percent owner, officer: Chief Operating Officer 1400 ST PAUL ST, SUITE 201, KELOWNA Z4 V1Y9N2